Job alert: Allergios is looking for a Scientific Project Manager
In July 2025, Dr. Holger Engel was appointed as CEO of Allergios to realign the company’s development efforts and prepare the platform for clinical applicability. The objective is clear: develop a robust, automatable version of the GranulEye® prototype to enable functional, cell-based allergy diagnostics in routine clinical settings. Since then,...
Allergios is proud to announce a public-private-partnership with Wageningen University & Research, supported by Health-Holland, Top Sector Life Sciences & Health. The objective of this partnership is to validate an innovative test for the diagnosis of food allergy, the GranulEye test. Dr. ir. Janneke Ruinemans-Koerts (clinical chemist at Rijnstate Hospital/Dicoon...